The role of ventriculoperitoneal shunting in patients with supratentorial glioma

Macarena I De La Fuente, Lisa M. Deangelis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: To assess the impact of ventriculoperitoneal (VPS) in patients with glioma. Methods: Retrospective review of patients with grade II-IV glioma who had VPS placement from January 1995 to November 2012. Results: We identified 62 patients. At time of VPS, 41 had gait disturbance, 40 cognitive impairment and 16 urinary incontinence; 10 had the classic triad. Thirty-eight (61%) improved after VPS. Median overall survival from VPS was 7 months for all patients, but 11 months for those who improved and 2 months for non-responders. Leptomeningeal disease, glioma grade or radiographic ventricular decompression did not predict benefit. Conclusions: VPS can improve functional status in some patients with symptoms suggestive of hydrocephalus.

Original languageEnglish (US)
Pages (from-to)45-48
Number of pages4
JournalAnnals of Clinical and Translational Neurology
Volume1
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Glioma
Urinary Incontinence
Hydrocephalus
Decompression
Gait
Survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

The role of ventriculoperitoneal shunting in patients with supratentorial glioma. / De La Fuente, Macarena I; Deangelis, Lisa M.

In: Annals of Clinical and Translational Neurology, Vol. 1, No. 1, 01.01.2014, p. 45-48.

Research output: Contribution to journalArticle

@article{715d6142f2674aee9c20c6d2090c3100,
title = "The role of ventriculoperitoneal shunting in patients with supratentorial glioma",
abstract = "Objectives: To assess the impact of ventriculoperitoneal (VPS) in patients with glioma. Methods: Retrospective review of patients with grade II-IV glioma who had VPS placement from January 1995 to November 2012. Results: We identified 62 patients. At time of VPS, 41 had gait disturbance, 40 cognitive impairment and 16 urinary incontinence; 10 had the classic triad. Thirty-eight (61{\%}) improved after VPS. Median overall survival from VPS was 7 months for all patients, but 11 months for those who improved and 2 months for non-responders. Leptomeningeal disease, glioma grade or radiographic ventricular decompression did not predict benefit. Conclusions: VPS can improve functional status in some patients with symptoms suggestive of hydrocephalus.",
author = "{De La Fuente}, {Macarena I} and Deangelis, {Lisa M.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/acn3.17",
language = "English (US)",
volume = "1",
pages = "45--48",
journal = "Annals of Clinical and Translational Neurology",
issn = "2328-9503",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - The role of ventriculoperitoneal shunting in patients with supratentorial glioma

AU - De La Fuente, Macarena I

AU - Deangelis, Lisa M.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objectives: To assess the impact of ventriculoperitoneal (VPS) in patients with glioma. Methods: Retrospective review of patients with grade II-IV glioma who had VPS placement from January 1995 to November 2012. Results: We identified 62 patients. At time of VPS, 41 had gait disturbance, 40 cognitive impairment and 16 urinary incontinence; 10 had the classic triad. Thirty-eight (61%) improved after VPS. Median overall survival from VPS was 7 months for all patients, but 11 months for those who improved and 2 months for non-responders. Leptomeningeal disease, glioma grade or radiographic ventricular decompression did not predict benefit. Conclusions: VPS can improve functional status in some patients with symptoms suggestive of hydrocephalus.

AB - Objectives: To assess the impact of ventriculoperitoneal (VPS) in patients with glioma. Methods: Retrospective review of patients with grade II-IV glioma who had VPS placement from January 1995 to November 2012. Results: We identified 62 patients. At time of VPS, 41 had gait disturbance, 40 cognitive impairment and 16 urinary incontinence; 10 had the classic triad. Thirty-eight (61%) improved after VPS. Median overall survival from VPS was 7 months for all patients, but 11 months for those who improved and 2 months for non-responders. Leptomeningeal disease, glioma grade or radiographic ventricular decompression did not predict benefit. Conclusions: VPS can improve functional status in some patients with symptoms suggestive of hydrocephalus.

UR - http://www.scopus.com/inward/record.url?scp=85011322624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011322624&partnerID=8YFLogxK

U2 - 10.1002/acn3.17

DO - 10.1002/acn3.17

M3 - Article

VL - 1

SP - 45

EP - 48

JO - Annals of Clinical and Translational Neurology

JF - Annals of Clinical and Translational Neurology

SN - 2328-9503

IS - 1

ER -